Lv1
48 积分 2021-09-03 加入
Tumor immune microenvironment remodeling predicts response to checkpoint inhibitor therapy
1个月前
已完结
A modular framework for antibody–drug conjugate biomarkers
1个月前
已完结
Advances in Systemic Treatment of Breast Cancer
1个月前
已完结
Clinical Advances in Breast Cancer: A Comprehensive Overview of Full‐Course Disease Management
1个月前
已完结
Outcomes of elacestrant in patients with ER-positive, HER2-negative, ESR1-mutated metastatic breast cancer who received prior endocrine therapy and cyclin-dependent kinase inhibitor in a real-world setting
1个月前
已关闭
The next 25 years of cancer research: emerging perspectives and priorities
2个月前
已完结
From CDK4/6 to CDK2 and KAT: Evolving therapeutic approaches in HR+/HER2– breast cancer
2个月前
已完结
Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2– Advanced Breast Cancer
2个月前
已完结
Imaging the hallmarks of cancer
3个月前
已完结
Therapeutic advances in HR+/HER2- advanced breast cancer after failure of CDK4/6 inhibitor therapy
3个月前
已完结